Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Short Interest Update

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) saw a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 60,200 shares, a growth of 29.2% from the September 30th total of 46,600 shares. Based on an average daily trading volume, of 3,380,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 2.5% of the company’s shares are sold short.

Catheter Precision Stock Performance

Shares of Catheter Precision stock traded down $0.01 during midday trading on Tuesday, reaching $0.55. 125,468 shares of the company’s stock traded hands, compared to its average volume of 1,075,311. Catheter Precision has a 12 month low of $0.31 and a 12 month high of $8.40.

Catheter Precision (NYSEAMERICAN:VTAK) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($5.57) EPS for the quarter. Catheter Precision had a negative return on equity of 50.02% and a negative net margin of 2,176.83%. The company had revenue of $0.09 million during the quarter. As a group, equities research analysts forecast that Catheter Precision will post -8.7 EPS for the current fiscal year.

About Catheter Precision

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.